The Crucial Role of Phase I Clinical Trials in Advancing Medicine; by David Walling, PhD The journey from a promising scientific discovery to a safe and effective medication available to the public is a complex and rigorous process. At the heart of this...
News at CenExel
Advancements in Vaccines: Bridging the Past and Future
Advancements in Vaccines: Bridging the Past and Future - by Nelia Sanchez-Crespo, MD The history of vaccines is a testament to the incredible progress we've made in protecting humanity against infectious diseases. From the invention of the smallpox...
Understanding Alzheimer’s Disease: Recognizing Warning Signs
Understanding Alzheimer's Disease: Recognizing Warning Signs - by Sanjiv Sharma, MD, CPI Alzheimer's disease is a progressive neurological disorder that affects millions of people worldwide. It's the most common cause of dementia among older adults and presents a...
FDA Approves ABRYSVO for RSV
In the last week, the FDA approved the first maternal vaccine designed to safeguard infants from respiratory syncytial virus (RSV) during the critical period immediately from birth up to 6 months of age, when they are most vulnerable to infection. RSV, a highly...
Ethnic Bridging: The Who, the When, the Why
In the dynamic realm of clinical drug development, a new star is rising: Ethnic Bridging clinical trials, also known as ethnobridging or Asian bridging clinical trials. Over the past several years, the industry has witnessed a surge in the adoption of these...
Placebo and Nocebo Response Mitigation
Empirical Strategies to Mitigate Placebo and Nocebo Effects CenExel sites are committed to enhancing understanding of the causes and implications of the placebo and nocebo effects within central nervous system and internal medicine clinical trials and developing...